Patients affected by ALK-1 positive ALCL have a significant better overall survival than ALK-1 negative ALCL patients (5-year overall survival: 70-80% vs. 33-49%) [14,15]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.